Independent information services

Services

Clear Almanac 74 organizes guides, comparisons, research summaries, and practical questions around ibogaine and drug addiction. The aim is careful context for people affected by substance use, families, and professionals—not a substitute for medical or legal advice.

For a wider starting point, the main ibogaine and addiction overview connects the substance-by-substance questions here with risks, alternatives, policy, and limits of the available evidence.

Close-up visual detail accompanying ibogaine and substance-specific addiction information — A structured resource for weighing questions before conclusions.

What is available

Information built for difficult decisions

These offerings are designed to make high-stakes claims easier to inspect. They do not tell anyone what treatment to choose, and they do not reduce a person’s needs to a single substance or intervention.

01 / Guides

Substance-by-substance guides

Plain-language guides distinguish the questions people raise about opioids, stimulants, alcohol, and other drugs. The guide can be used alongside the anti-addiction claims people encounter, while keeping evidence gaps and safety concerns visible.

02 / Comparisons

Decision frameworks

Comparison pages place ibogaine discussions beside established care, legal context, screening concerns, and practical uncertainty. Our approach and independence standards explain why careful sourcing and transparent limits matter.

03 / Research

Research summaries

Research summaries identify what a study can and cannot show. This includes interest in ibogaine and neuroplasticity, without treating a biological mechanism as proof of safety or effectiveness for any individual.

04 / Practical context

Access and setting questions

Practical explainers help readers recognize the difference between information, marketing, and medical care. They include context around U.S. ibogaine treatment center searches and why setting, oversight, and emergency planning are material questions.

A reading sequence

From claim to context

A service page should clarify the route through a topic, not oversimplify it. The sequence below is intended for reading and comparison, not self-assessment or treatment selection.

STEP 01

Name the substance

Begin with the specific drug and the specific question rather than assuming one account applies to every pattern of use.

STEP 02

Separate claims

Differentiate personal stories, early research, promotional language, and established treatment evidence.

STEP 03

Check safety context

Keep cardiac, psychiatric, interaction, withdrawal, and legal questions in view rather than treating them as fine print.

STEP 04

Compare options

Use credible treatment and support information to frame choices with uncertainty intact.

Evidence and safety

A guide is not a recommendation

Ibogaine has been discussed in relation to addiction, but it is not a routine, approved addiction treatment in the United States. The U.S. Food and Drug Administration explains how approval is used to establish that a drug’s benefits outweigh its known and potential risks for its intended use; see its drug development and approval process.

Our summaries also put terminology in context. The general definition of drug addiction describes a complex condition, which is one reason substance use questions should not be reduced to a single compound or a single narrative.

Readers looking at possible benefits can compare those discussions with the broader range of reported ibogaine benefits, while treating claims as claims until supported by appropriate evidence and safety information.

Comparison surface

What each information service is built to clarify

The same topic can require different kinds of reading. This comparison keeps the service boundaries visible.

Information service	Primary question	What it does not provide
Substance guide	How does the question change by substance and pattern of use?	Individual medical advice or withdrawal management.
Research summary	What does a study suggest, and what remains unknown?	A prediction of personal outcomes.
Comparison framework	What should be considered alongside ibogaine claims?	A recommendation for a provider or program.
Access explainer	What policy, setting, and oversight questions should be understood?	Legal advice or travel planning.

For example, a discussion of an ibogaine treatment experience can describe a commonly used term, but it cannot substitute for individualized screening, emergency preparedness, or professional care. Questions involving cross-border programs also benefit from reading the context around an ibogaine retreat in Mexico without assuming that location alone establishes quality or safety.

Common boundaries

FAQ

Does Clear Almanac 74 provide ibogaine treatment?

No. Clear Almanac 74 is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its role is to organize context around difficult questions.

Can a research summary decide whether ibogaine is appropriate?

No. A summary can clarify a study’s scope and limitations. It cannot evaluate personal health factors, medication interactions, or suitability for any person.

Why compare established treatment options?

Comparisons help prevent emerging claims from being read in isolation. The SAMHSA National Helpline information is one established public resource for people seeking treatment and support options in the United States.

Who are these services for?

They are for people affected by substance use, families, and professionals who want a careful frame for reading about ibogaine, risks, policy, access, and alternatives.

Clearer questions first

Use the guide to examine a claim, not to rush a conclusion.

Clear Almanac 74 keeps its scope deliberately narrow: evidence-first context, plain language, and transparent uncertainty around ibogaine and substance-specific addiction questions.

Open the substance guide